DEXAMETHASONE, CARFILZOMIB, DEXAMETHASONE, DEXAMETHASONE, CC-92480
Phase 2 small_molecule active
Quick answer
DEXAMETHASONE, CARFILZOMIB, DEXAMETHASONE, DEXAMETHASONE, CC-92480 for Patients with relapsed/refractory symptomatic multiple myeloma (MM) is a Phase 2 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pari Pharma GmbH
- Indication
- Patients with relapsed/refractory symptomatic multiple myeloma (MM)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active